180 Life Sciences — Perfil da empresa, notícias e dados financeiros

180 Life Sciences (NASDAQ:ATNF) is a biotechnology company focused on the development of novel therapies to combat inflammation, fibrosis, and pain. Operating at the cutting edge of medical research, their projects range from preclinical to Phase 2 clinical trials across various indications. These include addressing diseases such as Dupuytren’s contracture, Frozen shoulder, and Post-surgical pain, aiming to meet significant unmet medical needs. The objectives of 180 Life Sciences revolve around advancing these pioneering treatments through rigorous testing, aligning with regulatory approvals to eventually bring transformative solutions to patients globally. With a commitment to innovative science and patient well-being, they aim to lead advancements in biotechnology and therapeutic discovery.